RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 18.111
NA - Nord America 10.030
AS - Asia 8.524
SA - Sud America 1.428
Continente sconosciuto - Info sul continente non disponibili 597
AF - Africa 108
OC - Oceania 10
AN - Antartide 1
Totale 38.809
Nazione #
RU - Federazione Russa 12.636
US - Stati Uniti d'America 9.729
SG - Singapore 3.118
CN - Cina 1.760
IE - Irlanda 1.590
IT - Italia 1.455
HK - Hong Kong 1.419
BR - Brasile 1.181
VN - Vietnam 1.049
GB - Regno Unito 579
DE - Germania 522
FR - Francia 415
KR - Corea 354
IN - India 273
UA - Ucraina 253
SE - Svezia 150
CA - Canada 127
GR - Grecia 122
AR - Argentina 102
FI - Finlandia 98
JP - Giappone 94
TR - Turchia 71
AT - Austria 66
MX - Messico 64
BD - Bangladesh 62
ID - Indonesia 49
NL - Olanda 48
EC - Ecuador 42
AE - Emirati Arabi Uniti 39
PL - Polonia 36
IQ - Iraq 34
CO - Colombia 27
CZ - Repubblica Ceca 26
BE - Belgio 24
SA - Arabia Saudita 24
PK - Pakistan 23
TH - Thailandia 23
ZA - Sudafrica 23
CR - Costa Rica 21
JM - Giamaica 21
PY - Paraguay 20
ES - Italia 19
UZ - Uzbekistan 18
MA - Marocco 16
VE - Venezuela 16
EG - Egitto 15
HN - Honduras 15
JO - Giordania 13
PH - Filippine 13
CL - Cile 12
PE - Perù 12
IL - Israele 11
CH - Svizzera 10
EE - Estonia 10
LT - Lituania 9
MY - Malesia 9
NI - Nicaragua 9
SC - Seychelles 9
AU - Australia 8
DO - Repubblica Dominicana 8
LB - Libano 8
UY - Uruguay 8
AL - Albania 7
BO - Bolivia 7
NP - Nepal 7
OM - Oman 7
RO - Romania 7
TN - Tunisia 7
ET - Etiopia 6
KE - Kenya 6
PT - Portogallo 6
SN - Senegal 6
BB - Barbados 5
BG - Bulgaria 5
CI - Costa d'Avorio 5
DZ - Algeria 5
QA - Qatar 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AZ - Azerbaigian 4
EU - Europa 4
IR - Iran 4
KG - Kirghizistan 4
PA - Panama 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SV - El Salvador 4
BH - Bahrain 3
HU - Ungheria 3
KZ - Kazakistan 3
RS - Serbia 3
TW - Taiwan 3
AW - Aruba 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DK - Danimarca 2
GA - Gabon 2
Totale 38.180
Città #
Moscow 4.557
Dublin 1.585
Hong Kong 1.394
Singapore 1.309
Santa Clara 1.233
San Jose 1.184
Ashburn 1.037
Council Bluffs 868
Chandler 506
Jacksonville 467
Hefei 382
Seoul 350
Ho Chi Minh City 335
Princeton 264
Hanoi 246
Milan 245
Dallas 233
The Dalles 209
Roxbury 190
Beijing 188
Bengaluru 157
Naples 144
Bremen 130
Medford 123
Cambridge 115
São Paulo 96
New York 93
Munich 91
Los Angeles 89
Da Nang 81
Ann Arbor 75
Miano 75
Rome 70
Wilmington 70
Boardman 69
Nuremberg 64
Atlanta 61
Des Moines 53
North Bergen 49
San Mateo 48
Haiphong 47
Orem 40
Falkenstein 38
Tokyo 37
Caserta 36
Kochi 36
Belo Horizonte 35
Phoenix 35
Woodbridge 34
Chicago 33
Mexico City 31
Vienna 29
Rio de Janeiro 28
Frankfurt am Main 27
Warsaw 27
Guangzhou 26
Jinan 26
London 26
Montreal 26
Brooklyn 25
Florence 25
Brussels 24
Changsha 24
Houston 23
Amsterdam 22
Memphis 22
San Francisco 21
Tianjin 21
Aversa 20
Brno 20
Manchester 20
San José 20
Brasília 19
Chennai 19
Guarulhos 19
Toronto 19
Bologna 18
Bắc Ninh 18
Columbus 18
Shanghai 18
Shenyang 18
Stockholm 18
Boston 17
Denver 17
Hải Dương 17
Lappeenranta 17
Turku 17
Zhengzhou 17
Curitiba 16
Philadelphia 16
Tashkent 16
Porto Alegre 15
Hangzhou 14
Helsinki 14
Lusciano 14
Mumbai 14
Nanchang 14
Nanjing 14
Yan Ta Khao 14
Afragola 13
Totale 19.899
Nome #
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders 287
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 175
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 173
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 173
Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. 170
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 168
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 167
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 163
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 162
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 160
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 158
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 157
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 157
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 157
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 155
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 155
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 155
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 154
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 153
Acute myocarditis: prognostic role of speckle tracking echocardiography and comparison with cardiac magnetic resonance features 153
Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal 152
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 152
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 151
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 151
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 149
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 148
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 148
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 148
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 147
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 147
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 147
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 145
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 144
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management 144
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 143
Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. 143
Myocardial Work Efficiency in Physiologic Left Ventricular Hypertrophy of Power Athletes 142
Coronary sinus spasm during left ventricular lead implantation for biventricular pacing 142
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 142
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 141
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients 141
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 140
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 140
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 140
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 139
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 138
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 138
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 138
A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality 138
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 137
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 135
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 134
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 134
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 134
Advances in Nanomedicine for Precision Insulin Delivery 133
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 133
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 133
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation 132
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 131
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 131
Echocardiography in the Ventilated Patient: What the Clinician Has to Know 130
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 130
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study 130
Effects of High Intensity Interval Training Rehabilitation Protocol after an Acute Coronary Syndrome on Myocardial Work and Atrial Strain 130
Smartphone and new tools for Atrial Fibrillation diagnosis: evidence for clinical applicability 129
Put out the fire: The pleiotropic anti-inflammatory action of non-vitamin K oral anticoagulants 128
Biventricular pacing and heterogeneity of ventricular repolarization in heart failure patients 128
The role of multimodality imaging in athlete’s heart diagnosis: Current status and future directions 128
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 127
Relationship Between Left Atrial Strain and Atrial Fibrillation: The Role of Stress Echocardiography 127
Air entrapment as a cause of S-ICD inappropriate shocks 126
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 126
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis 126
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 125
Echocardiography in Cardiac Arrest: Incremental Diagnostic and Prognostic Role during Resuscitation Care 125
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 125
Superior vena cava thrombosis after intravascular AICD lead extraction: a case report 125
Giant coronary sinus in patient with double superior vena cava demonstrated by multislice computed tomography 125
TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS 125
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 125
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 124
111Ag phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project 123
Takotsubo Syndrome and Oxidative Stress: Physiopathological Linkage and Future Perspectives 122
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 122
Anti-arrhythmic properties of non-antiarrhythmic medications 122
Insulin resistance and cancer: molecular links and clinical perspectives 121
COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden 121
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 121
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 121
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 119
Migration of long-sensing vector implantable loop recorder unmasked by remote monitoring in patient with unexplained syncope 119
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 117
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 117
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. 116
Clinical Performance and Persistence on Dual Pathway Inhibition with Rivaroxaban and Aspirin in Real-World Setting 115
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 115
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 115
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network 115
Implantable Loop Recorder with Long Sensing Vector: Safety, Acceptability, and Sensing Performance in Pediatric Patients 114
Totale 13.940
Categoria #
all - tutte 137.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.298 0 0 0 46 395 4 8 33 39 145 199 429
2022/20232.500 256 29 38 180 235 172 9 110 1.374 28 37 32
2023/20241.110 70 39 50 64 448 51 44 19 11 29 78 207
2024/20255.241 30 46 19 68 752 664 447 447 757 1.086 452 473
2025/202621.838 915 1.133 1.331 1.212 1.705 11.710 1.264 814 883 377 302 192
2026/20274.560 213 583 1.948 1.816 0 0 0 0 0 0 0 0
Totale 38.809